Inventor · disambiguated record
Frederick R. Taylor
Also filed as: TAYLOR FREDERICK R · TAYLOR FREDERICK ROBBINS
16 granted patents·24 pending applications·306 citations·filing 1999–2025
94Inventor score
Top patents by PatentIndex Score
40 records- 0198US7863419B2Antibodies having altered effector function and methods for making the sameBIOGEN IDEC INC·Filed 2006·Granted Jan 4, 2011·140 cites·88 claims
- 0295US11571477B2Anti-VLA-4 antibodiesBIOGEN MA INC·Filed 2021·Granted Feb 7, 2023·2 cites·3 claims
- 0395US8784823B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2012·Granted Jul 22, 2014·38 cites·7 claims
- 0495US8293237B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofBURKLY LINDA C·Filed 2008·Granted Oct 23, 2012·40 cites·19 claims
- 0592US11053305B2Fusion protein constructs comprising anti-C3d antibody and CR1 polypeptideQ32 BIO INC·Filed 2020·Granted Jul 6, 2021·6 cites·35 claims
- 0691US10335485B2Anti-VLA-4 antibodiesBIOGEN MA INC·Filed 2017·Granted Jul 2, 2019·7 cites·6 claims
- 0788US11053306B2Fusion protein constructs comprising anti-C3d antibody and factor HQ32 BIO INC·Filed 2020·Granted Jul 6, 2021·2 cites·28 claims
- 0887US11083791B2Anti-VLA-4 antibodiesBIOGEN MA INC·Filed 2019·Granted Aug 10, 2021·4 cites·22 claims
- 0987US6897297B1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2000·Granted May 24, 2005·21 cites·51 claims
- 1085US8318917B2Nucleic acids encoding antibodies having altered effector function and methods for making the sameTAYLOR FREDERICK R·Filed 2010·Granted Nov 27, 2012·10 cites·77 claims
- 1181US2024100155A1Anti-vla-4 antibodiesBIOGEN MA INC·Filed 2023·Application pending·0 cites
- 1280US9902775B2Anti-blood dendritic cell antigen 2 antibodies and uses thereofBIOGEN MA INC·Filed 2013·Granted Feb 27, 2018·6 cites·53 claims
- 1380US2023135399A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB Biopharma SRL·Filed 2022·Application pending·0 cites
- 1479US9321840B2Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereofUCB PHARMA SA·Filed 2014·Granted Apr 26, 2016·2 cites·15 claims
- 1574US9738707B2Heterodimeric Fc regions, binding molecules comprising same, and methods relating theretoTAYLOR FREDERICK R·Filed 2012·Granted Aug 22, 2017·2 cites·33 claims
- 1668US11879008B2Methods of treating complement mediated diseases with fusion protein constructs comprising anti-C3d antibody and a complement modulatorQ32 BIO INC·Filed 2021·Granted Jan 23, 2024·0 cites·32 claims
- 1768US2009054632A1Hydrophobically-modified protein compositions and methodsBIOGEN IDEC INC·Filed 2007·Application pending·0 cites
- 1866US7479539B1Hedgehog fusion proteinsCURIS INC·Filed 2000·Granted Jan 20, 2009·3 cites·39 claims
- 1966US2019233530A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB BIOPHARMA SPRL·Filed 2019·Application pending·0 cites
- 2065US6444793B1Hydrophobically-modified hedgehog protein compositions and methodsCURIS INC·Filed 1999·Granted Sep 3, 2002·23 cites·27 claims
- 2165US2025304700A1Anti-blood dendritic cell antigen 2 antibodies and uses thereofBIOGEN MA INC·Filed 2025·Application pending·0 cites
- 2263US2005119181A1Hydrophobically-modified protein compositions and methodsCURIS INC·Filed 2004·Application pending·0 cites
- 2362US2024301043A1METHODS OF TREATING COMPLEMENT MEDIATED DISEASES WITH FUSION PROTEIN CONSTRUCTS COMPRISING ANTI-C3d ANTIBODY AND A COMPLEMENT MODULATORQ32 BIO INC·Filed 2023·Application pending·0 cites
- 2462US2006275283A1Fcgamma receptor-binding polypeptide variants and methods related theretoBIOGEN IDEC INC·Filed 2006·Application pending·0 cites
- 2559US2012003235A1Anti-lymphotoxin antibodiesRANGER ANN M·Filed 2009·Application pending·0 cites
- 2658US2008124278A1Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereofTAYLOR FREDERICK R·Filed 2007·Application pending·0 cites
- 2758US2015017155A1Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereofBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 2858US2016200823A1Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereofUCB PHARMA SA·Filed 2016·Application pending·0 cites
- 2955US2014161794A1Anti-vla-4 antibodiesLUGOVSKOY ALEXEY·Filed 2011·Application pending·0 cites
- 3053US2006193856A1Aglycosyl anti-CD154 (CD40 ligand) antibodies and uses thereofTAYLOR FREDERICK R·Filed 2005·Application pending·0 cites
- 3152US2010203046A1Fc gamma receptor-binding polypeptide variants and methods related theretoBIOGEN IDEC INC·Filed 2010·Application pending·0 cites
- 3251US2006172346A1Methods of designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteinsZHENG ZHONGLI·Filed 2005·Application pending·0 cites
- 3350US2018362652A1Anti-blood dendritic cell antigen 2 antibodies and uses thereofBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 3450US2004038876A1Polymer conjugates of hedgehog proteins and usesFiled 2002·Application pending·0 cites
- 3548US2003235861A1Methods for designing and producing novel compounds having improved binding affinity for CD154 or other trimeric proteinsFiled 2003·Application pending·0 cites
- 3648US2014079716A1Anti-lymphotoxin antibodiesBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 3746US2009258420A1Altered polypeptides, immunoconjugates thereof, and methods related theretoVAN VLIJMEN HERMAN·Filed 2008·Application pending·0 cites
- 3842US2007275481A1Methods For Detecting Half-Antibodies Using Chip Based Gel ElectophoresisBIOGEN IDEC INC·Filed 2004·Application pending·0 cites
- 3942US2012100140A1Stabilized fc polypeptides with reduced effector function and methods of useREYES CHRISTOPHER L·Filed 2010·Application pending·0 cites
- 4041US2004006208A1Co-crystal structure of monoclonal antibody 5C8 and CD154, and use thereof in drug designFiled 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Frederick R. Taylor files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →